Pacific Center for Financial Services’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-75
Closed -$1K 402
2022
Q2
$1K Hold
75
﹤0.01% 370
2022
Q1
$1K Hold
75
﹤0.01% 358
2021
Q4
$2K Hold
75
﹤0.01% 351
2021
Q3
$3K Hold
75
﹤0.01% 341
2021
Q2
$4K Hold
75
﹤0.01% 305
2021
Q1
$3K Hold
75
﹤0.01% 298
2020
Q4
$5K Buy
+75
New +$3.08K ﹤0.01% 274

Other funds holding EDIT

Pacific Center for Financial Services's EDIT Position: Q3 2022 in Review

Pacific Center for Financial Services sold out of Editas Medicine (EDIT) in Q3 2022, closing a stake of 75 shares — an estimated $1K sold.

Pacific Center for Financial Services first reported a position in EDIT in Q4 2020 and held it in 7 quarters. The position peaked at $5K in Q4 2020. 264 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

  • Pacific Center for Financial Services reported no remaining Editas Medicine position as of Q3 2022 after selling out during the quarter.
  • Pacific Center for Financial Services sold 75 Editas Medicine shares in Q3 2022, an estimated $1K.
  • Pacific Center for Financial Services first reported a position in Editas Medicine in Q4 2020 and held it in 7 quarters.
  • Pacific Center for Financial Services's Editas Medicine position peaked at $5K in Q4 2020.
  • 264 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Pacific Center for Financial Services's 13F filing for Q3 2022, filed 14 Nov 2022.